These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1527712)

  • 1. Cimetidine-carbaryl interaction in humans: evidence for an active metabolite of carbaryl.
    May DG; Naukam RJ; Kambam JR; Branch RA
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1057-61. PubMed ID: 1527712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tacrine oral clearance by cimetidine.
    Forgue ST; Reece PA; Sedman AJ; deVries TM
    Clin Pharmacol Ther; 1996 Apr; 59(4):444-9. PubMed ID: 8612390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbaryl metabolism is inhibited by cimetidine in the isolated perfused rat liver and in man.
    Ward SA; May DG; Heath AJ; Branch RA
    J Toxicol Clin Toxicol; 1988; 26(5-6):269-81. PubMed ID: 3143015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam.
    Greenblatt DJ; Locniskar A; Scavone JM; Blyden GT; Ochs HR; Harmatz JS; Shader RI
    Anesth Analg; 1986 Feb; 65(2):176-80. PubMed ID: 2935051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal interaction between itraconazole and cimetidine.
    Karyekar CS; Eddington ND; Briglia A; Gubbins PO; Dowling TC
    J Clin Pharmacol; 2004 Aug; 44(8):919-27. PubMed ID: 15286096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cimetidine on the pharmacokinetics of piroxicam in rat and man.
    Said SA; Foda AM
    Arzneimittelforschung; 1989 Jul; 39(7):790-2. PubMed ID: 2783182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered pharmacokinetics of oral flecainide by cimetidine.
    Tjandra-Maga TB; van Hecken A; van Melle P; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1986 Jul; 22(1):108-10. PubMed ID: 3741720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of carbamazepine metabolism by cimetidine.
    Grasela DM; Rocci ML
    Drug Metab Dispos; 1984; 12(2):204-8. PubMed ID: 6144486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbaryl and 1-naphthol tissue levels and related cholinesterase inhibition in male Brown Norway rats from preweaning to senescence.
    Moser VC; Phillips PM; McDaniel KL; Zehr RD; MacMillan DK; MacPhail RC
    J Toxicol Environ Health A; 2013; 76(20):1151-67. PubMed ID: 24279816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and toxicokinetics of carbaryl in chickens and rats: a comparative study.
    Ehrich M; Correll L; Strait J; McCain W; Wilcke J
    J Toxicol Environ Health; 1992 Aug; 36(4):411-23. PubMed ID: 1507271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.
    van Crugten J; Bochner F; Keal J; Somogyi A
    J Pharmacol Exp Ther; 1986 Feb; 236(2):481-7. PubMed ID: 3944769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cimetidine on the pharmacokinetics of single oral doses of alfuzosin.
    Desager JP; Harvengt C; Bianchetti G; Rosenzweig P
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):568-71. PubMed ID: 7904983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
    Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
    Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cimetidine on the pharmacokinetics of salicylic acid.
    Trnavská Z; Trnavský K; Smondrk J
    Drugs Exp Clin Res; 1985; 11(10):703-7. PubMed ID: 3836857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of drug interactions with single dose acenocoumarol: new screening method?
    Kroon C; de Boer A; Hoogkamer JF; Schoemaker HC; van der Meer EJ; Edelbroek PM; Cohen AF
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):355-60. PubMed ID: 2272718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.